Latest Technology News

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Insignia Financial reported a robust 2.2% increase in Funds Under Management and Administration to $326.8 billion in 2Q25, underpinned by strong net inflows and strategic milestones including the IT separation from NAB and the unveiling of its Vision2030 growth strategy.

Praemium has reported a record 29% increase in total Australian funds under administration (FUA) to $62.1 billion in Q2 FY2025, driven by strong net inflows and the successful launch of its next-generation IDPS, Spectrum.

Netwealth Group Limited has reported a record $4.5 billion in net inflows for the December 2024 quarter, marking a 69.8% increase year-on-year and driving its funds under administration past $100 billion.

Nanosonics delivers a robust H1 FY25 trading update, reporting an 18% rise in revenue to $93.6 million and a profit before tax of $10.9 million, signaling strong momentum in its infection prevention business.

Pure Hydrogen’s subsidiary HDrive International has secured a significant AUD$2 million order from logistics giant TOLL Transport for two Taurus 70t hydrogen fuel cell prime movers, marking a pivotal step in the company’s commercial vehicle sales expansion.

RocketDNA has reported its strongest quarter yet, breaking the $2 million revenue barrier and marking its first international export of the xBot® autonomous drone platform to a major African mining operation.

SelfWealth Ltd reported a 4% revenue increase and sustained profitability in H1 2025, while advancing a major transformation program and entering a proposed acquisition deal with Bell Financial Group.

Next Science reported a 2.9% revenue increase to US$22.8 million in FY24, driven by an 85% surge in XPERIENCE™ sales, while achieving adjusted EBITDA and cashflow positivity in 4Q FY24 amid strategic cost restructuring.

FleetPartners Group Limited reported a robust 13% increase in adjusted EPS for FY24, propelled by targeted market growth, operational transformation, and a disciplined share buy-back program. The company remains optimistic about sustaining momentum despite a modest dip in new business writings in early FY25.

FleetPartners Group Limited reported strong FY24 results with record new business writings and assets under management, underpinning a robust growth trajectory and a significant $30 million share buy-back announced for 1H25.

Cyclopharm has inked a pivotal three-year agreement with HCA Healthcare, enabling deployment of its Technegas® lung imaging technology across up to 169 US nuclear medicine departments. This deal marks a major step in expanding Technegas®’ footprint in the American healthcare market.